Sight Sciences CTO sells shares for tax withholding

Sight Sciences, Inc. director and Chief Technology Officer David Badawi reported an open-market sale of 8,168 shares of Common Stock at a weighted average price of $3.48 per share.

Accepted by SEC EDGAR 04/03/2026 - 04:28 PM EDT Learn about SEC filing dates

Rhea-AI Filing Summary

Sight Sciences, Inc. director and Chief Technology Officer David Badawi reported an open-market sale of 8,168 shares of Common Stock at a weighted average price of $3.48 per share. According to the footnotes, these shares were sold to cover his tax liability arising from the vesting of restricted stock units.

After this transaction, Badawi's reported holdings total 1,990,290 shares, consisting of 1,804,359 shares of common stock and 185,931 shares that will be acquired upon future vesting and settlement of restricted stock units. The sale represents a small portion of his overall position.

Insider Trade Summary 10b5-1

Net Seller: 8,168 shares

Net Sell 1 txn

Insider Badawi David

Role Chief Technology Officer

Sold 8,168 shs ($28K)

Type	Security	Shares	Price	Value
Sale	Common Stock	8,168	$3.48	$28K

Holdings After Transaction: Common Stock — 1,990,290 shares (Direct)

Footnotes (3)

1. F1. Reflects shares of the Issuer's common stock, par value $0.001 per share ("Common Stock"), sold to cover the Reporting Person's tax liability in connection with the vesting of restricted stock units ("RSUs").
2. F2. Reflects the weighted average price at which the shares of Common Stock were sold. The shares were sold in multiple transactions at prices ranging from $3.43 to $3.59, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
3. F3. Includes (i) 1,804,359 shares of common stock, and (ii) 185,931 shares of common stock which shall be acquired upon the vesting and settlement of restricted stock units that have not yet vested.

Key Figures

Shares sold: 8,168 shares Sale price: $3.48 per share Total holdings after sale: 1,990,290 shares +2 more

5 metrics

Shares sold 8,168 shares Open-market sale on 2026-04-02 to cover tax liability

Sale price $3.48 per share Weighted average price; trades ranged $3.43–$3.59

Total holdings after sale 1,990,290 shares Common stock and RSUs reported following the transaction

Common stock held 1,804,359 shares Portion of post-transaction holdings in common stock

Unvested RSU-linked shares 185,931 shares Shares to be acquired upon vesting and settlement of RSUs

Key Terms

restricted stock units ("RSUs"), weighted average price, vesting and settlement

3 terms

restricted stock units ("RSUs") financial

"in connection with the vesting of restricted stock units ("RSUs")."

Restricted stock units (RSUs) are a company promise to give an employee shares of stock (or cash equivalent) in the future, but only after certain conditions—usually staying with the company for a set time or hitting performance goals—are met. Investors watch RSUs because when they vest they increase the number of shares outstanding and can lead insiders to sell shares, affecting share price, company dilution and the true cost of employee pay.

weighted average price financial

"Reflects the weighted average price at which the shares of Common Stock were sold."

Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.

vesting and settlement financial

"shares of common stock which shall be acquired upon the vesting and settlement of restricted stock units"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did SGHT CTO David Badawi report?

David Badawi reported selling 8,168 shares of Sight Sciences common stock. The filing states this sale was made to cover his tax liability from vesting restricted stock units, rather than a discretionary portfolio change, and was executed at a weighted average price of $3.48 per share.

At what price were David Badawi’s SGHT shares sold?

The reported weighted average sale price was $3.48 per share. Footnotes explain the shares were sold in multiple transactions, with individual prices ranging from $3.43 to $3.59, and Badawi offers to provide full breakdowns of share counts at each separate price upon request.

How many SGHT shares does David Badawi hold after this Form 4?

After the reported transaction, David Badawi holds 1,990,290 shares linked to Sight Sciences. This includes 1,804,359 shares of common stock and 185,931 additional shares that will be received when currently unvested restricted stock units vest and are settled in the future.

Why did David Badawi sell SGHT shares according to the filing?

The filing explains that the shares were sold to cover Badawi’s tax liability from vesting restricted stock units. This indicates the sale was tied to compensation-related tax obligations, rather than a purely discretionary open-market decision to reduce his economic exposure to Sight Sciences stock.

What does the weighted average price range mean in the SGHT Form 4?

The weighted average price reflects that multiple trades occurred between $3.43 and $3.59 per share. The filing notes the 3.48 figure averages those prices, and states that detailed information about share amounts at each specific price level is available upon request from interested parties.

How significant is the 8,168-share SGHT sale relative to Badawi’s holdings?

The 8,168 shares sold represent a small fraction of Badawi’s 1,990,290 total reported shares. Because most of his position remains intact, and the sale is described as tax-related, the transaction appears routine in scale compared with his overall economic stake in Sight Sciences.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Badawi David

(Last) (First) (Middle)

C/O SIGHT SCIENCES, INC.

4040 CAMPBELL AVE., SUITE 100

(Street)

MENLO PARK CALIFORNIA 94025

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Sight Sciences, Inc. [ SGHT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Technology Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
04/02/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	04/02/2026		S		8,168(1)	D	$3.48(2)	1,990,290(3)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Reflects shares of the Issuer's common stock, par value $0.001 per share ("Common Stock"), sold to cover the Reporting Person's tax liability in connection with the vesting of restricted stock units ("RSUs").

2. Reflects the weighted average price at which the shares of Common Stock were sold. The shares were sold in multiple transactions at prices ranging from $3.43 to $3.59, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

3. Includes (i) 1,804,359 shares of common stock, and (ii) 185,931 shares of common stock which shall be acquired upon the vesting and settlement of restricted stock units that have not yet vested.

	/s/Jeremy Hayden, Attorney-in-Fact for David Badawi	04/03/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)